4//SEC Filing
LaCascia Michael 4
Accession 0000899243-20-031581
CIK 0001822462other
Filed
Nov 17, 7:00 PM ET
Accepted
Nov 18, 8:18 PM ET
Size
5.5 KB
Accession
0000899243-20-031581
Insider Transaction Report
Form 4
LaCascia Michael
Chief Legal Officer
Transactions
- Award
Stock Option (Right to Buy)
2020-11-17+162,162→ 162,162 totalExercise: $17.00Exp: 2030-11-16→ Common Stock (162,162 underlying)
Footnotes (1)
- [F1]25% of the shares underlying the stock option shall vest on November 9, 2021, with the remainder vesting in 12 substantially equal quarterly installments thereafter, subject to the Reporting Person's continued service with the Issuer through such applicable vesting dates.
Documents
Issuer
Foghorn Therapeutics Inc.
CIK 0001822462
Entity typeother
Related Parties
1- filerCIK 0001831755
Filing Metadata
- Form type
- 4
- Filed
- Nov 17, 7:00 PM ET
- Accepted
- Nov 18, 8:18 PM ET
- Size
- 5.5 KB